We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current LGVN market cap is 26.41M. The company's latest EPS is USD and P/E is N/A.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 150k | 63k | 548k | 468k | 773k |
| Operating Income | -5.16M | -5.44M | -4.09M | -3.5M | -4.65M |
| Net Income | -5.9M | -6.03M | -4.06M | -11.91M | -4.57M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 5.64M | 5.63M | 1.31M | 1.22M | 709k |
| Operating Income | -3M | -3.78M | -17.46M | -18.04M | -21.03M |
| Net Income | -2.96M | -3.72M | -17.05M | -18.84M | -22.21M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 11.63M | 12.08M | 9.7M | 19.39M | 29.91M |
| Total Liabilities | 4.99M | 5.34M | 6.66M | 4.48M | 4.28M |
| Total Equity | 6.63M | 6.74M | 3.04M | 14.91M | 25.63M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 10.58M | 9.24M | 42.77M | 27.41M | 12.08M |
| Total Liabilities | 6.14M | 7.28M | 5.31M | 6.91M | 5.34M |
| Total Equity | 4.45M | 1.96M | 37.45M | 20.5M | 6.74M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -15.01M | -19M | -3.09M | -7.65M | -10.5M |
| Investing | 6.62M | 8.19M | 14k | -39k | -517k |
| Financing | -153k | 5.26M | 63k | 15.12M | 28.84M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -2.39M | -2.36M | -9.64M | -13.97M | -19M |
| Investing | -125k | -262k | -10.7M | -677k | 8.19M |
| Financing | 350k | 1.58M | 45.16M | -509k | 5.26M |
| Market Cap | 26.41M |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 14.84M |
| Average Volume (1 week) | 246.93k |
| Average Volume (1 Month) | 304.08k |
| 52 Week Change | -91.32% |
| 52 Week High | 21.70 |
| 52 Week Low | 0.7707 |
| Spread (Intraday) | 0.02 (1.11%) |
| Company Name | Longeveron Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https:///www.longeveron.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
